Double-blind Randomized Controlled Trial of Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary) ; Levobupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 13 Dec 2013 Planned End Date changed from 1 Oct 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 24 Jun 2013 Planned End Date changed from 1 Mar 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 22 Oct 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.